Abraxane 100 mg intravenous suspension

Original price was: $1,400.00.Current price is: $1,100.00.

ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy